Tumour necrosis factor alpha as a therapeutic target for immune-mediated inflammatory diseases.

Tumour necrosis factor alpha as a therapeutic target for immune-mediated inflammatory diseases.

Preclinical studies have identified and validated tumour necrosis factor alpha (TNFalpha) as a key disease molecule and therapeutic target for immunotherapeutic intervention in many immune-mediated inflammatory diseases. Clinical indications include rheumatoid arthritis, Crohn's disease, ankylo...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Taylor, P, Williams, R, Feldmann, M
Format:	Journal article
Język:	English
Wydane:	2004

Podobne zapisy

Cartilage destruction and bone erosion in arthritis: the role of tumour necrosis factor alpha.
od: Williams, R, i wsp.
Wydane: (2000)

Selective immunosuppression of tumour necrosis factor-alpha in rheumatoid arthritis.
od: Brennan, F, i wsp.
Wydane: (1995)

What is the mechanism of action of anti-tumour necrosis factor-alpha antibody in rheumatoid arthritis?
od: Feldmann, M
Wydane: (1996)

Beneficial effects of tumour necrosis factor-alpha (TNF-alpha) blockade in rheumatoid arthritis (RA)
od: Maini, R, i wsp.
Wydane: (1995)

Anaemia of chronic disease in rheumatoid arthritis: in vivo effects of tumour necrosis factor alpha blockade.
od: Davis, D, i wsp.
Wydane: (1997)

The effect of tumour necrosis factor-alpha (TNF-alpha) muteins on human neutrophils in vitro.
od: Tchorzewski, H, i wsp.
Wydane: (1993)

Tumour necrosis factor-alpha gene polymorphisms and Alzheimer's disease.
od: Culpan, D, i wsp.
Wydane: (2003)

Paradoxical effects of tumour necrosis factor-alpha in adjuvant-induced arthritis.
od: Williams, R
Wydane: (2008)

The role of receptors for tumour necrosis factor-alpha in the induction of human polymorphonuclear neutrophil chemiluminescence.
od: Zeman, K, i wsp.
Wydane: (1996)

New approaches to therapeutic immunomodulation for immune-mediated inflammatory disorders.
od: Taylor, P, i wsp.
Wydane: (2004)

Antagonism of tumour necrosis factor alpha in refractory asthma.
od: Berry, M, i wsp.
Wydane: (2008)

Inhibitory effects of bisbenzylisoquinolines on synthesis of the inflammatory cytokines interleukin-1 and tumour necrosis factor-alpha
od: W. Kim Seow, i wsp.
Wydane: (1993-01-01)

Detection of in vivo production of tumour necrosis factor-alpha by human thyroid epithelial cells.
od: Zheng, R, i wsp.
Wydane: (1992)

A single-cell therapeutic atlas of anti-tumour necrosis factor therapy in inflammatory bowel disease
od: Thomas, T, i wsp.
Wydane: (2023)

Tumor necrosis factor-alpha: a promising therapeutic target for asthma?
od: Heffler, E, i wsp.
Wydane: (2007)

Contrasting effects of interferon gamma and interleukin 4 on responses of human vascular endothelial cells to tumour necrosis factor alpha.
od: Paleolog, E, i wsp.
Wydane: (1992)

Mechanism of immune complex-mediated damage: induction of interleukin 1 by immune complexes and synergy with interferon-gamma and tumor necrosis factor-alpha.
od: Chantry, D, i wsp.
Wydane: (1989)

Tumour Necrosis Factor Superfamily Members in the Pathogenesis of Inflammatory Bowel Disease
od: Tomasz J. Ślebioda, i wsp.
Wydane: (2014-01-01)

Expression of tumour necrosis factor alpha (TNF alpha) and lysozyme in necrotizing enterocolitis (NEC)
od: Lala, S, i wsp.
Wydane: (2002)

Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis.
od: Elliott, M, i wsp.
Wydane: (1994)

A longitudinal single-cell therapeutic atlas of anti-tumour necrosis factor treatment in inflammatory bowel disease
od: Thomas, T
Wydane: (2023)

The role of tumour necrosis factor alpha stimulated gene-6 on bone
od: Afrough, S
Wydane: (2016)

Current state of tumour necrosis factor {alpha} blockade in Wegener's granulomatosis.
od: Mukhtyar, C, i wsp.
Wydane: (2005)

Paradoxical Roles of Tumour Necrosis Factor-Alpha in Prostate Cancer Biology
od: Brian W. C. Tse, i wsp.
Wydane: (2012-01-01)

Increased concentration of tumour necrosis factor alpha in the plasma of glaucoma patients
od: Trenkić Marija, i wsp.
Wydane: (2024-01-01)

Tumour necrosis factor.
od: Van Der Merwe, P
Wydane: (1988)

Immunomodulatory parasites and toll-like receptor-mediated tumour necrosis factor alpha responsiveness in wild mammals
od: Ralli Catriona, i wsp.
Wydane: (2009-04-01)

The neutrophil migration induced by tumour necrosis factor alpha in mice is unaffected by glucocorticoids
od: C. A. Cecilio, i wsp.
Wydane: (1997-01-01)

Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1 alpha.
od: Buchan, G, i wsp.
Wydane: (1988)

Anti-tumor necrosis factor alpha therapy of rheumatoid arthritis. Mechanism of action.
od: Feldmann, M, i wsp.
Wydane: (1997)

Therapeutic actions of cyclosporine and anti-tumor necrosis factor alpha in collagen-induced arthritis and the effect of combination therapy.
od: Williams, R, i wsp.
Wydane: (1998)

Endometriosis Classification and The Role of Tumor Necrosis Factor-Alpha Polymorphisms as A Therapeutic Target
od: Fabio Barra, i wsp.
Wydane: (2020-04-01)

Tumour necrosis factor alpha (TNF) gene haplotypes and primary sclerosing cholangitis
od: Cullen, SN, i wsp.
Wydane: (2003)

Treatment of intestinal Behcet's syndrome with chimeric tumour necrosis factor alpha antibody.
od: Travis, S, i wsp.
Wydane: (2001)

Should histoplasmosis be screened for before initiation of tumour necrosis factor alpha inhibitors?
od: Srujan Edupuganti, i wsp.
Wydane: (2024-04-01)

Evaluation of salivary tumour necrosis factor–alpha in patients with recurrent aphthous stomatitis
od: Shruthi Hegde, i wsp.
Wydane: (2018-09-01)

Evaluation of salivary tumour necrosis factor–alpha in patients with recurrent aphthous stomatitis
od: Ananya Madi̇yal, i wsp.
Wydane: (2018-09-01)

Tumour Necrosis Factor-alpha and Nuclear Factor-kappa B Gene Variants in Sepsis
od: Leyla Acar, i wsp.
Wydane: (2018-02-01)

Tumour necrosis factor synergises with gamma interferon on the induction of mRNA for DR alpha chain on thyrocytes from Graves' disease and non toxic goitre.
od: Kissonerghis, A, i wsp.
Wydane: (1989)

A comparative study into the mechanisms of action of anti-tumor necrosis factor alpha, anti-CD4, and combined anti-tumor necrosis factor alpha/anti-CD4 treatment in early collagen-induced arthritis.
od: Marinova-Mutafchieva, L, i wsp.
Wydane: (2000)